263 related articles for article (PubMed ID: 24929097)
21. Antiretroviral therapy in resource-limited settings 1996 to 2006: patient characteristics, treatment regimens and monitoring in sub-Saharan Africa, Asia and Latin America.
; Keiser O; Anastos K; Schechter M; Balestre E; Myer L; Boulle A; Bangsberg D; Touré H; Braitstein P; Sprinz E; Nash D; Hosseinipour M; Dabis F; May M; Brinkhof MW; Egger M
Trop Med Int Health; 2008 Jul; 13(7):870-9. PubMed ID: 18373510
[TBL] [Abstract][Full Text] [Related]
22. Retention in care prior to antiretroviral treatment eligibility in sub-Saharan Africa: a systematic review of the literature.
Plazy M; Orne-Gliemann J; Dabis F; Dray-Spira R
BMJ Open; 2015 Jun; 5(6):e006927. PubMed ID: 26109110
[TBL] [Abstract][Full Text] [Related]
23. Prior exposure to antiretroviral therapy among adult patients presenting for HIV treatment initiation or reinitiation in sub-Saharan Africa: a systematic review.
Benade M; Maskew M; Juntunen A; Flynn DB; Rosen S
BMJ Open; 2023 Nov; 13(11):e071283. PubMed ID: 37984944
[TBL] [Abstract][Full Text] [Related]
24. Treatment guidelines and early loss from care for people living with HIV in Cape Town, South Africa: A retrospective cohort study.
Katz IT; Kaplan R; Fitzmaurice G; Leone D; Bangsberg DR; Bekker LG; Orrell C
PLoS Med; 2017 Nov; 14(11):e1002434. PubMed ID: 29136014
[TBL] [Abstract][Full Text] [Related]
25. Impact on ART initiation of point-of-care CD4 testing at HIV diagnosis among HIV-positive youth in Khayelitsha, South Africa.
Patten GE; Wilkinson L; Conradie K; Isaakidis P; Harries AD; Edginton ME; De Azevedo V; van Cutsem G
J Int AIDS Soc; 2013 Jul; 16(1):18518. PubMed ID: 23830642
[TBL] [Abstract][Full Text] [Related]
26. Reliability of absolute lymphocyte count as a marker to assess the need to initiate antiretroviral therapy in HIV-infected children.
Shah I; Parikh S
J Postgrad Med; 2012; 58(3):176-9. PubMed ID: 23023348
[TBL] [Abstract][Full Text] [Related]
27. Factors Associated with Timing of Initiation of Antiretroviral Therapy among HIV-1 Infected Adults in the Niger Delta Region of Nigeria.
Ogoina D; Finomo F; Harry T; Inatimi O; Ebuenyi I; Tariladei WW; Afolayan AA
PLoS One; 2015; 10(5):e0125665. PubMed ID: 25933356
[TBL] [Abstract][Full Text] [Related]
28. Interventions to improve or facilitate linkage to or retention in pre-ART (HIV) care and initiation of ART in low- and middle-income settings--a systematic review.
Govindasamy D; Meghij J; Kebede Negussi E; Clare Baggaley R; Ford N; Kranzer K
J Int AIDS Soc; 2014; 17(1):19032. PubMed ID: 25095831
[TBL] [Abstract][Full Text] [Related]
29. Monitoring and switching of first-line antiretroviral therapy in adult treatment cohorts in sub-Saharan Africa: collaborative analysis.
Haas AD; Keiser O; Balestre E; Brown S; Bissagnene E; Chimbetete C; Dabis F; Davies MA; Hoffmann CJ; Oyaro P; Parkes-Ratanshi R; Reynolds SJ; Sikazwe I; Wools-Kaloustian K; Zannou DM; Wandeler G; Egger M;
Lancet HIV; 2015 Jul; 2(7):e271-8. PubMed ID: 26423252
[TBL] [Abstract][Full Text] [Related]
30. Effectiveness of antiretroviral therapy in HIV-infected children under 2 years of age.
Penazzato M; Prendergast A; Tierney J; Cotton M; Gibb D
Cochrane Database Syst Rev; 2012 Jul; (7):CD004772. PubMed ID: 22786492
[TBL] [Abstract][Full Text] [Related]
31. Optimal monitoring strategies for guiding when to switch first-line antiretroviral therapy regimens for treatment failure in adults and adolescents living with HIV in low-resource settings.
Chang LW; Harris J; Humphreys E
Cochrane Database Syst Rev; 2010 Apr; (4):CD008494. PubMed ID: 20393969
[TBL] [Abstract][Full Text] [Related]
32. Alcohol Use and Antiretroviral Therapy Non-Adherence Among Adults Living with HIV/AIDS in Sub-Saharan Africa: A Systematic Review and Meta-Analysis.
Velloza J; Kemp CG; Aunon FM; Ramaiya MK; Creegan E; Simoni JM
AIDS Behav; 2020 Jun; 24(6):1727-1742. PubMed ID: 31673913
[TBL] [Abstract][Full Text] [Related]
33. Characteristics and response to antiretroviral therapy of HIV-1-infected patients born in Africa and living in France.
Breton G; Lewden C; Spire B; Salmon D; Brun-Vézinet F; Duong M; Allavena C; Leport C; Salamon R;
HIV Med; 2007 Apr; 8(3):164-70. PubMed ID: 17461860
[TBL] [Abstract][Full Text] [Related]
34. Simplified clinical algorithm for identifying patients eligible for same-day HIV treatment initiation (SLATE): Results from an individually randomized trial in South Africa and Kenya.
Rosen S; Maskew M; Larson BA; Brennan AT; Tsikhutsu I; Fox MP; Vezi L; Bii M; Venter WDF
PLoS Med; 2019 Sep; 16(9):e1002912. PubMed ID: 31525187
[TBL] [Abstract][Full Text] [Related]
35. From policy to practice: exploring the implementation of antiretroviral therapy access and retention policies between 2013 and 2016 in six sub-Saharan African countries.
Ambia J; Renju J; Wringe A; Todd J; Geubbels E; Nakiyingi-Miiro J; Urassa M; Lutalo T; Crampin AC; Kwaro D; Kyobutungi C; Chimbindi N; Gomez-Olive FX; Tlhajoane M; Njamwea B; Zaba B; Mee P
BMC Health Serv Res; 2017 Nov; 17(1):758. PubMed ID: 29162065
[TBL] [Abstract][Full Text] [Related]
36. When to start antiretroviral therapy in resource-limited settings.
Walensky RP; Wolf LL; Wood R; Fofana MO; Freedberg KA; Martinson NA; Paltiel AD; Anglaret X; Weinstein MC; Losina E;
Ann Intern Med; 2009 Aug; 151(3):157-66. PubMed ID: 19620143
[TBL] [Abstract][Full Text] [Related]
37. The cascade of care following community-based detection of HIV in sub-Saharan Africa - A systematic review with 90-90-90 targets in sight.
Sabapathy K; Hensen B; Varsaneux O; Floyd S; Fidler S; Hayes R
PLoS One; 2018; 13(7):e0200737. PubMed ID: 30052637
[TBL] [Abstract][Full Text] [Related]
38. The clock is ticking: the rate and timeliness of antiretroviral therapy initiation from the time of treatment eligibility in Kenya.
Odeny TA; DeCenso B; Dansereau E; Gasasira A; Kisia C; Njuguna P; Haakenstad A; Gakidou E; Duber HC
J Int AIDS Soc; 2015; 18(1):20019. PubMed ID: 26507824
[TBL] [Abstract][Full Text] [Related]
39. Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes.
May M; Boulle A; Phiri S; Messou E; Myer L; Wood R; Keiser O; Sterne JA; Dabis F; Egger M;
Lancet; 2010 Aug; 376(9739):449-57. PubMed ID: 20638120
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of the impact of immediate versus WHO recommendations-guided antiretroviral therapy initiation on HIV incidence: the ANRS 12249 TasP (Treatment as Prevention) trial in Hlabisa sub-district, KwaZulu-Natal, South Africa: study protocol for a cluster randomised controlled trial.
Iwuji CC; Orne-Gliemann J; Tanser F; Boyer S; Lessells RJ; Lert F; Imrie J; Bärnighausen T; Rekacewicz C; Bazin B; Newell ML; Dabis F;
Trials; 2013 Jul; 14():230. PubMed ID: 23880306
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
